Amalgamated Bank’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,373
| Closed | -$2K | – | 3179 |
|
2024
Q1 | $2K | Sell |
1,373
-2,332
| -63% | -$3.4K | ﹤0.01% | 2909 |
|
2023
Q4 | $3K | Sell |
3,705
-409
| -10% | -$331 | ﹤0.01% | 2976 |
|
2023
Q3 | $4K | Hold |
4,114
| – | – | ﹤0.01% | 2991 |
|
2023
Q2 | $11K | Sell |
4,114
-908
| -18% | -$2.43K | ﹤0.01% | 2947 |
|
2023
Q1 | $20K | Sell |
5,022
-795
| -14% | -$3.17K | ﹤0.01% | 2659 |
|
2022
Q4 | $29K | Hold |
5,817
| – | – | ﹤0.01% | 2640 |
|
2022
Q3 | $76K | Buy |
5,817
+96
| +2% | +$1.25K | ﹤0.01% | 2277 |
|
2022
Q2 | $73K | Buy |
5,721
+1,788
| +45% | +$22.8K | ﹤0.01% | 2309 |
|
2022
Q1 | $60K | Buy |
+3,933
| New | +$60K | ﹤0.01% | 2387 |
|